FDA NDC Directory · JSON-LD · Markdown

ITVISMA

NDC 71894-200 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic nameonasemnogene abeparvovec-brve
Labeler / ManufacturerNovartis Gene Therapies, Inc.
Marketing categoryBiologic License Application · App BLA125856
Dosage form / routeINJECTION, SUSPENSION · INTRATHECAL
Active ingredientsONASEMNOGENE ABEPARVOVEC (40000000000000 [arb'U]/mL)
Marketing started20251124
Package count1

External sources

Source: openFDA. Public-domain (CC0).